Natco Pharma Limited (NATCOPHARM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE987B01026
Key metrics
- Market Cap
- ₹15,488 Cr
- P/E Ratio
- 13.3
- EPS
- 63.87
- Book Value
- 514.83
- P/B Ratio
- 1.63
- ROE
- 15.38%
- ROCE
- 12.38%
- Debt / Equity
- 0.08
- Net Margin
- 34.78%
- Revenue Growth
- -7.93%
- Profit Growth
- -24.76%
- Dividend Yield
- 0.77%
- 52W High
- ₹1,226.80
- 52W Low
- ₹789.00
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Natco Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 50.95%
The full Natco Pharma Limited analysis
Create a free account to open the complete NATCOPHARM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.